Related Experiment Video
Updated: May 28, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
E4F1 dysfunction results in autophagic cell death in myeloid leukemic cells
Elodie Hatchi1, Geneviève Rodier, Claude Sardet
1Institut de Génétique Moléculaire de Montpellier, Université de Montpellier, IFR122, Montpellier, France.
The E4F1 protein promotes survival in myeloid leukemia by affecting mitochondria and reactive oxygen species (ROS). Inactivating E4F1 causes tumor regression, offering potential new AML therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Mechanisms
Background:
- The E4F1 protein, an adenovirus E1A target, is linked to oncogenic pathways, but its role in tumorigenesis is not fully understood.
- Previous research has implicated E4F1 in cancer, yet its specific functions in tumor development and maintenance require further elucidation.
Purpose of the Study:
- To investigate the role of the E4F1 protein in myeloid leukemia.
- To explore the therapeutic potential of targeting E4F1 in cancer treatment.
Main Methods:
- Utilized a genetically engineered mouse model of myeloid leukemia (histiocytic sarcomas, HS) with Ink4a/Arf locus inactivation.
- Performed genetic ablation of E4F1 in established tumors and analyzed downstream effects on cell death pathways.
- Assessed E4F1 expression in human acute myeloid leukemia (AML) cell lines and patient samples.
Main Results:
- Genetic inactivation of E4F1 in established myeloid tumors led to significant tumor regression in vivo.
- E4F1 ablation triggered mitochondrial dysfunction, increased reactive oxygen species (ROS) levels, and induced massive autophagic cell death in transformed myeloid cells.
- E4F1 depletion induced cell death in human myeloid leukemic cell lines, including AML, and E4F1 was found to be overexpressed in a significant proportion of human AML samples.
Conclusions:
- E4F1 plays a critical, previously unsuspected role in the survival of leukemic cells.
- E4F1 inactivation triggers a cascade leading to autophagic cell death in myeloid leukemia, suggesting E4F1 as a potential therapeutic target.
- These findings offer new insights into E4F1-driven tumorigenesis and pave the way for novel therapeutic strategies against AML.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Lysosomal Hydrolases
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Extrinsic Apoptotic Pathway

